Lifecore Biomedical, Inc. \De\ (LFCR) Depreciation & Amortization (CF) (2010 - 2025)

Lifecore Biomedical, Inc. \De\'s Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $1.9 million for Q2 2025.

• In Q2 2025, Depreciation & Amortization (CF) fell 4.97% year-over-year to $1.9 million; the TTM figure through May 2025 stood at $8.0 million (up 0.92% YoY), while the FY2025 annual figure was $8.0 million, up 0.92% from the prior year.
• Depreciation & Amortization (CF) for Q2 2025 stood at $1.9 million, down from $2.1 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $14.8 million in Q1 2021, with the low at $1.8 million in Q4 2023.
• The 5-year median for Depreciation & Amortization (CF) is $2.8 million (2022), against an average of $3.7 million.
• The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization (CF) jumped 216.21% in 2021, then tumbled 76.01% in 2022.
• Lifecore Biomedical, Inc. \De\'s Depreciation & Amortization (CF) stood at $5.9 million in 2021, then sank by 50.41% to $2.9 million in 2022, then tumbled by 39.93% to $1.8 million in 2023, then climbed by 15.74% to $2.0 million in 2024, then decreased by 6.36% to $1.9 million in 2025.
• Business Quant data shows LFCR's Depreciation & Amortization (CF) at $1.9 million in Q2 2025, $2.1 million in Q1 2025, and $2.0 million in Q4 2024.